Calamos Supports Greece

FDA

Pfizer Granted Priority Review for FDA Vaccine Approval

Last Friday, the US FDA granted pharmaceutical companies Pfizer and BioNTech priority review designation for their coronavirus vaccine.

Moderna Says Vaccine Safe for Teens, Will Submit to FDA

The Moderna pharmaceutical company announced on Tuesday that its mRNA vaccine, now only given to adults, is highly effective in adolescents.

Coronavirus Cases, Intubations See Steep Rise in Greece

The number of coronavirus cases diagnosed in Greece in the last 24 hours saw a sharp increase, along with those undergoing intubation.

FDA Approves Use of Pfizer’s Covid-19 Vaccine in Children Aged 12-15

Children aged 12 to 15 can receive Pfizer's Covid-19 vaccine, the United States’ Food and Drug Administration announced on Monday.

US Pivots, Distributing Vaccine According to Demand — Not Population

The White House announced Tuesday that it will distribute coronavirus vaccines according to demand, marking a shift in vaccine distribution.

US May Authorize Pfizer Vaccine For Children By Next Week

The United States may authorize Pfizer's vaccine for children aged 12 to 15 as soon as next week, CEO Albert Bourla said on Tuesday.

FDA Calls for Halt to Administration of Johnson & Johnson Vaccine

The USFDA called for a halt to federally-sponsored inoculation campaigns using the Johnson & Johnson vaccine.

EU Drug Regulators Say AstraZeneca Vaccine Benefits Outweigh Risks

The EMA said that the benefits of the AstraZeneca vaccine still outweigh any potential risk of blood clot formation.

Johnson & Johnson Sends New Vaccine to FDA For Approval

The American Food and Drug Administration will begin to review the Johnson & Johnson vaccine, which the company states is 100% effective at preventing hospitalizations and deaths from Covid-19, on February 26. The Johnson & Johnson product -- in contrast...

Moderna Vaccine Gets OK from FDA; EU to Receive 160 Million Doses

The coronavirus vaccine developed by the American pharmaceutical firm Moderna, based in Cambridge, Massachusetts, along with the National Institute of Allergy and Infectious Diseases (NIAID) was cleared by the FDA on Friday after receiving the all-important thumbs-up from its independent...